Literature DB >> 12359119

Mediators in nasal polyposis.

Claus Bachert1, Philippe Gevaert, Gabriele Holtappels, Paul van Cauwenberge.   

Abstract

Nasal polyposis (NP) is a chronic inflammatory disease of the sinuses often associated with asthma. Although we have not yet achieved a full understanding of the precise mechanisms underlying the pathogenesis of NP, recent insights have been acquired into the regulation of eosinophil chemotaxis, activation, and survival, in addition to their possible link to gross histopathologic changes such as pseudocyst formation. Interleukin (IL)-5, transforming growth factor-beta(1), and eotaxin seem to be crucial players in the regulation of eosinophilic inflammation and extracellular matrix breakdown. The cytokine pattern in NP assumes neither a T helper 1 (Th1) nor Th2 type predominance, because IL-4, IL-5, IL-12, and interferon-gamma have all been shown to be upregulated in NP tissue, without influence of the atopic status. However, recent studies have demonstrated a strong local upregulation of the immunoglobulin E (IgE) synthesis with the formation of specific IgE to Staphylococcus aureus enterotoxins, suggesting a possible role of superantigens in these pathologic processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359119     DOI: 10.1007/s11882-002-0088-9

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  42 in total

1.  Immunoglobulins in nasal polyp fluid.

Authors:  R Donovan; S G Johansson; H Bennich; J F Soothill
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

2.  Nasal polyps and bronchial asthma.

Authors:  J R Moloney; J Collins
Journal:  Br J Dis Chest       Date:  1977-01

3.  Nasal polyps: effects of seasonal allergen exposure.

Authors:  P K Keith; M Conway; S Evans; D A Wong; G Jordana; D Pengelly; J Dolovich
Journal:  J Allergy Clin Immunol       Date:  1994-03       Impact factor: 10.793

Review 4.  Latent transforming growth factor-beta: structural features and mechanisms of activation.

Authors:  J S Munger; J G Harpel; P E Gleizes; R Mazzieri; I Nunes; D B Rifkin
Journal:  Kidney Int       Date:  1997-05       Impact factor: 10.612

5.  Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils.

Authors:  S H Shin; J Y Park; C H Jeon; J K Choi; S H Lee
Journal:  Laryngoscope       Date:  2000-08       Impact factor: 3.325

6.  Cytokine gene expression in nasal polyps.

Authors:  C H Lee; C S Rhee; Y G Min
Journal:  Ann Otol Rhinol Laryngol       Date:  1998-08       Impact factor: 1.547

7.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.

Authors:  P D Ponath; S Qin; D J Ringler; I Clark-Lewis; J Wang; N Kassam; H Smith; X Shi; J A Gonzalo; W Newman; J C Gutierrez-Ramos; C R Mackay
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

8.  Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES.

Authors:  M Ebisawa; T Yamada; C Bickel; D Klunk; R P Schleimer
Journal:  J Immunol       Date:  1994-09-01       Impact factor: 5.422

Review 9.  The role of cytokines in infectious sinusitis and nasal polyposis.

Authors:  C Bachert; M Wagenmann; C Rudack; K Höpken; M Hillebrandt; D Wang; P van Cauwenberge
Journal:  Allergy       Date:  1998-01       Impact factor: 13.146

10.  Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors.

Authors:  Y Yamaguchi; T Suda; J Suda; M Eguchi; Y Miura; N Harada; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  10 in total

1.  Increased expression of chemokine receptors CCR1 and CCR3 in nasal polyps: molecular basis for recruitment of the granulocyte infiltrate.

Authors:  P Fundová; D P Funda; D Kovář; R Holý; M Navara; H Tlaskalová-Hogenová
Journal:  Folia Microbiol (Praha)       Date:  2012-10-11       Impact factor: 2.099

2.  Interleukin 5, IL6, IL12, IFN-gamma, RANTES and Fractalkine in human nasal polyps, turbinate mucosa and serum.

Authors:  Arild Danielsen; Turid Tynning; Karl A Brokstad; Jan Olofsson; Ake Davidsson
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-02-03       Impact factor: 2.503

3.  Serum amyloid A, properdin, complement 3, and toll-like receptors are expressed locally in human sinonasal tissue.

Authors:  Andrew P Lane; Quynh-Ai Truong-Tran; Allan Myers; Carol Bickel; Robert P Schleimer
Journal:  Am J Rhinol       Date:  2006 Jan-Feb

4.  Pathophysiology of nasal congestion.

Authors:  Robert M Naclerio; Claus Bachert; James N Baraniuk
Journal:  Int J Gen Med       Date:  2010-04-08

5.  Damage-associated molecular patterns stimulate interleukin-33 expression in nasal polyp epithelial cells.

Authors:  Gina Paris; Tatyana Pozharskaya; Tomefa Asempa; Andrew P Lane
Journal:  Int Forum Allergy Rhinol       Date:  2014-01       Impact factor: 3.858

Review 6.  Actual concepts in rhinosinusitis: a review of clinical presentations, inflammatory pathways, cytokine profiles, remodeling, and management.

Authors:  Philippe Eloy; Anne Lise Poirrier; Clotilde De Dorlodot; Thibaut Van Zele; Jean Baptiste Watelet; Bernard Bertrand
Journal:  Curr Allergy Asthma Rep       Date:  2011-04       Impact factor: 4.806

7.  Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells.

Authors:  Stina Feltenmark; Narinder Gautam; Asa Brunnström; William Griffiths; Linda Backman; Charlotte Edenius; Lennart Lindbom; Magnus Björkholm; Hans-Erik Claesson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-09       Impact factor: 11.205

Review 8.  Superantigens and nasal polyps.

Authors:  Claus Bachert; Thibaut van Zele; Philippe Gevaert; Lore De Schrijver; Paul Van Cauwenberge
Journal:  Curr Allergy Asthma Rep       Date:  2003-11       Impact factor: 4.919

9.  Differential expression of tumor necrosis factor α, interleukin 1β, nuclear factor κB in nasal mucosa among chronic rhinosinusitis patients with and without polyps.

Authors:  Danuta Plewka; Alicja Grzanka; Elzbieta Drzewiecka; Andrzej Plewka; Maciej Misiołek; Grażyna Lisowska; Beata Rostkowska-Nadolska; Radoslaw Gawlik
Journal:  Postepy Dermatol Alergol       Date:  2017-05-29       Impact factor: 1.837

10.  Distinct characteristics of nasal polyps with and without eosinophilia.

Authors:  Changzhi Sun; Hong Ouyang; Renzhong Luo
Journal:  Braz J Otorhinolaryngol       Date:  2016-04-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.